U.S. Construction Stock News

CareTrust REIT has delivered a strong 131.3% total return over the past 5 years, yet the current valuation checks and recent share price pullback invite a closer look at whether the stock still offers good value after that run. Over 5 years, a 131.3% return places CareTrust REIT among the stronger performers, which can reduce the margin of safety if earnings and cash flow do not keep pace. The recent announcement of US$291 million in new investments and a US$1.5b year to date total may...

Why STAAR Surgical’s Latest Earnings Are Getting Fresh Attention STAAR Surgical (STAA) has returned to profitability in its latest report, which is a key reason the stock is back in focus for many investors this week. See our latest analysis for STAAR Surgical. STAAR Surgical’s latest earnings and leadership changes have arrived alongside a mixed price picture, with a 7.67% year to date share price return contrasting with a 5 year total shareholder return that is down 82.32%. This suggests...

DICK'S Sporting Goods stock has delivered a strong 123.7% return over the past 5 years, yet on today's numbers it screens as roughly in line with fair value rather than a clear bargain or an obvious excess. Recent short term weakness and a mixed set of valuation checks mean investors now have to weigh solid long term gains against a more balanced pricing picture. Over 5 years, DICK'S Sporting Goods has returned 123.7%, which suggests long term holders have already captured a substantial...

On Holding (NYSE:ONON) is back in focus after its second quarter revenue came in below analyst estimates and the company lowered its full year sales growth outlook, prompting a sharp share price reaction. See our latest analysis for On Holding. The sharp reaction to the Q2 update sits on top of a weaker recent trend for On Holding, with the 7-day share price return down 18.8% and the year-to-date share price return down 33.95%. The 3-year total shareholder return is 2.28%, suggesting short...

Why Packaging Corporation of America Stock Is In Focus After Q2 Results Packaging Corporation of America (PKG) drew investor attention after Q2 results matched revenue expectations but missed on EPS and guidance. The company also set a record for total corrugated shipments and reported emerging corrugated price increases. See our latest analysis for Packaging Corporation of America. The Q2 update arrived after a strong run in Packaging Corporation of America’s share price, with a 30-day share...

Simon Property Group has delivered a 124.9% total return over the past 5 years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the stock still trades at a discount to its estimated worth. With fresh headlines around higher potential rent from Saks Global store closures and a separate family dispute over real estate assets, investors are weighing how much of this is already reflected in the share price. Over 5 years,...

Symbotic Inc. has reported third-quarter 2026 results showing revenue of US$720.84 million and net income of US$11.67 million, and has issued fourth-quarter revenue guidance of US$760 million to US$780 million while adding veteran investor Steve Pagliuca to its Board of Directors. The shift from a net loss to a profit over both the quarter and nine-month period highlights improving operational efficiency as Symbotic scales its warehouse automation business. Next, we’ll examine how Symbotic’s...

Chipotle Mexican Grill (NYSE: CMG) has relaunched its Chipotle IQ interactive trivia campaign for loyalty members in the U.S. and Canada. The latest Chipotle IQ round adds new reward mechanics, physical game sweepstakes, and daily streak features for participants. The campaign continues to highlight Chipotle's focus on customer engagement and loyalty program incentives. For investors watching how consumer brands use promotions to strengthen loyalty and potential future sales, it can be...

SailPoint (SAIL) has drawn fresh attention after a recent special call, followed closely by the launch of its Identity Security solution, which targets both human and non-human identities in increasingly complex AI driven environments. See our latest analysis for SailPoint. The recent Identity Security launch and special call appear to sit alongside a sharp shift in sentiment. SailPoint’s 30 day share price return of 33.69% and 90 day share price return of 42.11% contrast with a year to date...

Western Union (NYSE:WU) has launched Stablecard, a digital wallet and Visa-backed credit card built around the USDPT stablecoin for cross-border payments and money transfers. The new product uses blockchain infrastructure to support global transactions and everyday spending for users who hold USDPT. Stablecard is designed to appeal to customers in markets with unstable local currencies by offering a dollar-linked digital balance for remittances and payments. The launch extends Western...

Protalix BioTherapeutics shares jumped 7.8% to US$2.62 into the close, and that move captures only part of the story. The stock came into this print already on a strong run over the past three months. Today’s reaction, however, appears to lean more on emotion than on new information. The focus is on margin and profitability. Q2 net income reached US$3.8m with earnings per share of US$0.05, supported by US$19.9m in revenue and a cash balance of about US$40.7m with no debt. The market appears...

CAVA Group stock just ripped 14.3% in a single session, yet the real story sits in the income statement, not the ticker tape. You are watching a high expectation stock with a rich 131.3x trailing P/E trade as if Q2 settled a lot of doubts in one go. The headline is simple: Strong Q2 restaurant performance and 9% same restaurant sales growth landed on top of a business that still runs on a slim 4.8% trailing net margin. The move looks like the market rewarding momentum while largely setting...

What Tootsie Roll Industries’ Latest Earnings Reveal Tootsie Roll Industries (TR) reported second quarter and first half 2026 results on August 7, with stable revenue but lower net income and earnings per share compared with the same periods in 2025. For the second quarter, revenue was US$154.22 million compared with US$155.09 million a year earlier. Net income was US$13.35 million compared with US$17.54 million, and basic earnings per share from continuing operations was US$0.18 compared...

CoreWeave went into this print with a hot growth story and a stock that had already run hard. Then the earnings drop hit and the market punched the accelerator. The share price jumped about 19% to US$107.73, a sharp move for a company already priced on high expectations. The reason sits squarely in the top line and in operating leverage. Revenue for the quarter landed at US$2.6b and adjusted earnings before interest, tax, depreciation and amortisation margin reached 59%. For an AI...

Cooling inflation and a less aggressive Federal Reserve are quietly reshaping the backdrop for U.S. consumer discretionary and retail stocks. With headline CPI at 3.4% and core inflation at 2.5%, real purchasing power may be starting to breathe again, which could matter a lot for select retailers and brands. This article walks through three stocks exposed to this macro turn and why they might deserve a closer look right now. The stocks covered below are just a starting sample, and the full...

Belite Bio recently announced that the U.S. FDA has accepted and granted Priority Review to its New Drug Application for tinlarebant to treat Stargardt Disease Type 1, with a PDUFA target action date set for February 12, 2027. If approved, tinlarebant would become the first FDA‑approved treatment for this rare inherited retinal disease, highlighting Belite Bio’s potential role in addressing a significant unmet medical need. We will now examine how FDA Priority Review for tinlarebant, with a...

Nurix Therapeutics recently reported earning a US$10 million milestone payment from Sanofi for advancing its oral STAT6 degrader into a Phase 1 trial, while also enrolling the first patient in a global Phase 3 study of its BTK degrader bexobrutideg in partnership with Roche for relapsed or refractory CLL/SLL. Together, these updates highlight how Nurix’s DEL-AI protein degradation platform is now translating into late-stage clinical programs and tangible partnership revenues under its Sanofi...

Krystal Biotech earnings and revenue momentum come into focus Krystal Biotech (KRYS) is back in the spotlight after reporting second quarter 2026 results that included net income of US$54.77 million and basic earnings per share from continuing operations of US$1.85. See our latest analysis for Krystal Biotech. The recent earnings update and 24% net product revenue growth for VYJUVEK came after a strong run, with Krystal Biotech posting a year to date share price return of 34.81% and a 1 year...

DuPont de Nemours (NYSE: DD) has been selected to supply its MemCor membrane bioreactor system for the upgrade of the Lower Molonglo Water Quality Control Centre in Australia. The facility is the largest inland wastewater treatment plant in the country and is being upgraded to support population growth and more resilient water infrastructure. The project highlights DuPont's Water Solutions business and its role in advanced treatment technologies for global water infrastructure. This kind of...

In early August 2026, Netlist, Inc. announced it had entered into a five-year alliance with Samsung covering a patent portfolio cross-license, memory product supply, technology cooperation, and the settlement of all pending legal actions, with Samsung also agreeing to purchase 10 million Netlist shares. This agreement gives Samsung access to Netlist’s full server DIMM and High Bandwidth Memory patent portfolio while securing DRAM and NAND supply for Netlist, marking a material shift in...

Cooling inflation, softer rate expectations and cheaper fuel have shifted the ground for smaller U.S. consumer and travel stocks, but not all in the same way. Some companies may see a little more room on pricing and margins, while others could feel the pinch from still sticky shelter costs. This article walks through three stocks from a small-cap screener that appear positively exposed to this latest CPI backdrop. The stocks highlighted below are only a starting sample from this idea, and the...

Aquestive Therapeutics stock slipped about 4% today, even though the headline from Q2 is more about balance sheet breathing room than a collapse in the story. The company ended the quarter with US$98.5m in cash and reaffirmed full year 2026 guidance for revenue in the US$46m to US$50m range and a non GAAP adjusted EBITDA loss of US$35m to US$30m. For a small biopharma stock that trades on belief in future products, that mix of liquidity, steady guidance and ongoing losses is what is really...

IMAX stock has delivered a very strong 261.7% return over the past 5 years, yet the valuation checks send mixed signals as the Discounted Cash Flow (DCF) estimate points to meaningful upside while market multiples lean expensive. Over 5 years IMAX has returned 261.7%, which puts extra focus on whether recent gains are already pricing in much of the long term opportunity. The recent record IMAX performance for "Spider-Man: Brand New Day" in China can support expectations for premium format...

Why NuScale Power Stock Is Back in Focus After a Major Capital Raise NuScale Power (SMR) has moved back onto investors’ radar after the company filed for a US$750 million follow on equity offering of Class A common stock through an at the market program. See our latest analysis for NuScale Power. At around US$9.59 per share, NuScale Power has seen short term momentum pick up with a 30 day share price return of 14.85%. However, the share price is still down 41.20% year to date and the 1 year...